relapse
103 results
1 - 100- relapse
- marker-only relapse
- recrudescence
- inebilizumab
- recurrence
- dimethyl fumarate
- esketamine
- peginterferon alfa-2B
- recidivity
- PART
- ocrelizumab
- palindromia
- diroximel fumarate
- monomethyl fumarate
- alemtuzumab
- disease-free survival
- salvage therapy
- marker
- tositumomab (I 131 tositumomab)
- peginterferon beta-1a
- duration of response
- interferon beta-1a
- cladribine
- AMPHOTERICIN B
- recidivation
- retrocession
- interferon beta-1b
- vincristine liposome
- minimal residual disease
- ISOtretinoin
- dalfampridine
- response
- Antithyrotropin Receptor Antibodies: Binding Inhibition Antibodies and Stimulating Antibodies
- eculizumab
- gallium nitrate
- L-tryptophan
- pseudorelapse of multiple sclerosis
- pamidronate
- varenicline (systemic)
- epinephrine
- griseofulvin
- artemether-lumefantrine
- alendronate
- nystatin (oral)
- acamprosate
- Multiple Sclerosis
- PACLitaxel
- mefloquine
- brentuximab vedotin
- interferon alpha-2b
- onychomycosis
- Guillain-Barré Syndrome
- Cholinesterases: Acetylcholinesterase, Pseudocholinesterase and Dibucaine Number
- dermatitis
- Myasthenia Gravis
- inotuzumab ozogamicin
- Aplastic Anemia
- Cytomegalovirus Infection
- Syphilis
- IgG4-related systemic disease
- doxapram
- etidronate
- Bladder Cancer
- Lupus Erythematosus
- Mikulicz-Radecki, Johann von
- Tonsillitis
- cloZAPine
- calcitonin (salmon)
- trimipramine
- toxic shock syndrome
- Lymphoma, Non-Hodgkin
- lenalidomide
- riTUXimab
- trichinosis
- Crohn disease
- Hodgkin Lymphoma
- pancreatitis
- psychosis
- poisoning
- Psychoactive Substance Abuse
- Lyme disease